- Home
- Services
- usa connecticut
- clinical screening trial
Refine by
Clinical Screening Trial Services In Usa Connecticut
6 services found
by:MPR Associates based inAlexandria, VIRGINIA (USA)
MPR specializes in total product development, handling all aspects of product development from the initial conceptualization and definition stages, concurrently integrating engineering and design, to rapidly prototype full systems, fabricate units for clinical trials, and manage technology transfer activities to manufacturers for full-scale ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s medical image analysis team develops robust algorithms and pipelines to solve complex image science problems. Our team of over fifty medical image processing scientists, including more than twenty PhDs, is responsible for extracting scientific quantitative data in support of Invicro’s studies from discovery research through late-phase clinical trials. The medical image ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro is an medical imaging CRO with over 210 scientists, 60+ PhD’s and MD’s and 2100+ qualified imaging centers across the globe. We possess scientific and regulatory expertise, project management scale and operational excellence to manage all the clinical trial imaging components of your Phase I-IV clinical trials across the therapeutic spectrum and spanning imaging ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s Advanced Pathology Services (APS) team provides end-to-end solutions to support translational and clinical research by providing a combination of routine and unique tissue testing services. As part of the REALM IDx, Inc. group, our pathology service laboratories support projects spanning preclinical biomarker discovery research to clinical trials and development of companion ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of radiopharmaceuticals requires a partner that has extensive ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...